Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Ferrarini

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
Haematologica|August 29, 2020
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokinesPaolo Giannoni, Cecilia Marini, Giovanna Cutrona, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
British Journal of Haematology|September 12, 2014
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational studyFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Immunologic Research|August 31, 2015
A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytesBrian A McCarthy, Sophia Yancopoulos, Mike Tipping, et al.
Blood|August 24, 2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patientsMassimo Gentile, Tait D Shanafelt, Davide Rossi, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2016
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)Francesca Valdora, Giovanna Cutrona, Serena Matis, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Non-Coding RNA|September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective StudyEnnio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
American Journal of Hematology|November 4, 2017
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed casesMassimo Gentile, Tait D Shanafelt, Francesca R Mauro, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Expert Opinion on Investigational Drugs|June 20, 2020
TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitorsFortunato Morabito, Massimo Gentile, Paola Monti, et al.
Haematologica|August 29, 2020
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokinesPaolo Giannoni, Cecilia Marini, Giovanna Cutrona, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
British Journal of Haematology|September 12, 2014
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational studyFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Immunologic Research|August 31, 2015
A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytesBrian A McCarthy, Sophia Yancopoulos, Mike Tipping, et al.
Blood|August 24, 2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patientsMassimo Gentile, Tait D Shanafelt, Davide Rossi, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2016
A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)Francesca Valdora, Giovanna Cutrona, Serena Matis, et al.
Plos One|March 19, 2015
Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemiaFrancesco Maura, Laura Mosca, Sonia Fabris, et al.
Non-Coding RNA|September 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective StudyEnnio Nano, Francesco Reggiani, Adriana Agnese Amaro, et al.
American Journal of Hematology|November 4, 2017
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed casesMassimo Gentile, Tait D Shanafelt, Francesca R Mauro, et al.
Pageof 13